Literature DB >> 20483618

Isolated osteoradionecrosis of the dens mimicking metastasis of nasopharyngeal carcinoma after radiotherapy.

Jung-Shun Lee1, Chih-Ming Huang, I-Chun Yeh, Helen Hai-Wen Chen, Jin-Ching Lin, Hsing-Hong Chen.   

Abstract

Nasopharyngeal carcinoma (NPC) is common in southern China, and radiotherapy remains the mainstay of treatment. A rare late complication of this treatment is the development of osteoradionecrosis (ORN), which seldom involves the cervical spine. We describe a 47-year-old female with undifferentiated carcinoma of the nasopharynx, stage II (T2N0M0), who had undergone radiotherapy 51 months prior, and complained of a twitching headache on neck flexion/extension. Imaging studies, including MRI and 18-fluoro-2-deoxyglucose positron emission tomography scan, suggested the diagnosis of cervical spinal metastasis. However, plasma Epstein-Barr virus DNA was undetectable, favoring absence of tumor recurrence. The patient underwent atlantoaxial sublaminar wiring for an unstable spine and a subsequent transoral biopsy, the histopathologic diagnosis of ORN. The postoperative clinical course was uneventful and follow-up MRI, 2 years later, revealed gradual resolution of the lesion. To our knowledge this is the first report of an isolated ORN lesion of the dens confirmed surgically in a patient with a history of previously treated NPC, a lesion at the cervical spine, and inconclusive imaging and biological marker results. We recommend that ORN be suspected until proven otherwise in a previously irradiated patient. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20483618     DOI: 10.1016/j.jocn.2009.10.037

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Cervical spine complications after treatment of nasopharyngeal carcinoma.

Authors:  Jason Pui-Yin Cheung; William I Wei; Keith Dip-Kei Luk
Journal:  Eur Spine J       Date:  2012-12-01       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.